Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Cardiac Fibrosis, Diastolic Dysfunction

In brief

The purpose of this study is to determine whether Pycnogenol, a natural pine bark extract, is effective in modifying the age-dependent process of cardiac fibrosis and diastolic function in aged hypertensive subjects.

Key facts

Study ID
NCT00952627
Run by
University of Arizona
People needed
9
Starts
2009-07-01
Expected to finish
2011-07-01
Last updated by the study team
2013-12-17

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.